Zai Lab's Cancer Drug Zocilurtatug Pelitecan Receives FDA Fast Track Status

Zai Lab announced that its cancer drug, zocilurtatug pelitecan, has been granted Fast Track status by the U.S. Food and Drug Administration (FDA).